Palmar pustular psoriasis associated with teriflunomide treatment

Mult Scler Relat Disord. 2019 Jan:27:400-402. doi: 10.1016/j.msard.2018.11.020. Epub 2018 Nov 19.

Abstract

Background: Cutaneous adverse effects of Teriflunomide have been rarely reported.

Objective and methods: We report a relapsing remitting multiple sclerosis patient that developed palmar pustular psoriasis within one month of teriflunomide initiation.

Results: Our patient required discontinuation of teriflunomide due to frequent recurrence of pustules with continuous need of local steroid treatment and resolved completely after teriflunomide discontinuation.

Conclusion: Pustular psoriasis can be triggered by medications but has not been previously reported in association with teriflunomide treatment, to the best of our knowledge.

Keywords: Adverse effect; Disease-modifying therapy; Multiple sclerosis; Pustular psoriasis; Teriflunomide.

Publication types

  • Case Reports

MeSH terms

  • Crotonates / adverse effects*
  • Female
  • Humans
  • Hydroxybutyrates
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / complications
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Nitriles
  • Psoriasis / chemically induced*
  • Psoriasis / pathology
  • Toluidines / adverse effects*

Substances

  • Crotonates
  • Hydroxybutyrates
  • Nitriles
  • Toluidines
  • teriflunomide